Philips Electronics’ most recent patent application (US Pub. 2020306494) proves they are still the leaders in the Sleep portion of the AI Biotech: Neurology sector. The ‘6494 application teaches a method that monitors a user’s electrical brain activity via electroencephalogram (EEG) while they sleep. Using AI, the headband automatically applies varying levels of neurostimulation to enhance the wearer’s Non-Rapid Eye Movement, thereby providing a deeper and more restful sleep.

Although Philips does not have the largest IP portfolio in the AI Biotech/Diagnostics sector as a whole, they do lead the field in the sleep subcategory. Interestingly, of the other top 5 contenders in the Neurology sector, only IBM and Philips have any IP in the sleep category. Psomagen Inc., is focused strictly on the microbiome category, and Halo Neuro and Boston Scientific are both split evenly between the General and Specific diagnostics categories. It is also worth noting that Phillips has a few documents in the Mental State category as well. For an interactive view of the market leaders and their patent portfolios, make sure to subscribe to the Magic Number® AI Biotech/Diagnostic Patent Forecast®.